Clinical Trial Update: Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 four-way crossover trial in healthy volunteers comparing ferric maltol capsules with an oral suspension to assess pharmacokinetics and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferric Maltol capsules (ferric maltol)
• Ferric Maltol oral suspension (ferric maltol)

Snippet

Sponsor: Shield Therapeutics | Conditions: Anemia, Iron Deficiency | Phase 1 | Status: COMPLETED | Results posted: 2025-08-24